Wira Winardi

Banda, AC 23111, Indonesia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Interleukin-1α-Mediated Activation of TNF-α/NF-κB Signaling Confers Resistance to Osimertinib in EGFR-Mutant Non-Small-Cell Lung Cancer.

Interleukin-1α-Mediated Activation of TNF-α/NF-κB Signaling Confers Resistance to Osimertinib in EGFR-Mutant Non-Small-Cell Lung Cancer.

Journal: Thoracic cancer
Published: March 14, 2026

Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and Extra-Terminal Domain Inhibitors.

Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and Extra-Terminal Domain Inhibitors.

Journal: Cancer science
Published: November 29, 2024

Splicing junction-based classifier for the detection of abnormal constitutive activation of the KEAP1-NRF2 system.

Splicing junction-based classifier for the detection of abnormal constitutive activation of the KEAP1-NRF2 system.

Journal: NPJ systems biology and applications
Published: July 19, 2024

Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer.

Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer.

Journal: Respiratory investigation
Published: January 17, 2024

Anti-Müllerian hormone type II receptor protein expression in non-small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation.

Anti-Müllerian hormone type II receptor protein expression in non-small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation.

Journal: Thoracic cancer
Published: December 24, 2023

Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.

Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.

Journal: Cancers
Published: January 07, 2023

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.

Journal: Thoracic cancer
Published: November 13, 2022

Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia.

Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia.

Journal: Infectious disease reports
Published: November 09, 2022

Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia.

Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia.

Journal: Vaccines
Published: September 23, 2022

Monkeypox: A Comprehensive Review.

Monkeypox: A Comprehensive Review.

Journal: Viruses
Published: September 11, 2022

Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia.

Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia.

Journal: Journal of preventive medicine and public health = Yebang Uihakhoe chi
Published: May 30, 2022

Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective.

Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective.

Journal: Narra J
Published: April 20, 2022
Showing 1-12 of 25

Last Updated: 09/26/2026